Eight research areas, one catalogue
Every compound we stock belongs to at least one research conversation. This page is the index of those conversations: what each area studies, how strong its literature is, and where the products and reading live.
Areas first, compounds second
The catalogue can be read two ways. Product-first: find a compound, read its page, check its certificate. Or area-first: start from a research question, see which compounds the literature attaches to it, and work inward. This page serves the second route.
Each area page follows the same contract: what the field actually studies, what the evidence honestly supports, which compounds we stock for it, and what to read next. Where a literature is thin, the page says thin — the sleep area is four sentences of candour for a reason.
Areas overlap, deliberately. NAD+ appears under energy and features in the knowledge base as not being a peptide at all; the GLP-1 class anchors weight but reaches into metabolic work broadly. The links between pages are the map; every page connects to its neighbours.
Pick your question
One line of honest summary each. The pages carry the rest.
Weight research
The incretin class: one receptor family, three generations of compounds, and the deepest trial data on this site.
Read MuscleMuscle and performance
Growth hormone secretagogues and the pulsatility argument — plus the heaviest anti-doping overlap in the catalogue.
Read RecoveryRecovery and repair
BPC-157, TB-500 and the injury-model literature: substantial in animals, absent in humans, stated as such.
Read SkinSkin research
GHK-Cu and the dermal work — the corner of the field with the most direct line to established cosmetic science.
Read CognitionCognition research
Semax, selank and dihexa: compounds from research traditions the Western literature is still catching up with.
Read EnergyEnergy and longevity
NAD+, MOTS-c, SS-31 and epitalon — mitochondria, ageing claims, and the widest gap between hype and data.
Read SleepSleep research
The smallest area, essentially DSIP and honesty about a literature that never grew.
Read LibidoLibido research
PT-141 and oxytocin: central mechanisms rather than vascular ones, and one genuinely approved molecule.
ReadPages that serve every area
Whatever the research question, these four apply.
About the areas
How this index relates to the rest of the site.
Why organise by research area rather than by compound?
Do the areas overlap?
Are all areas equally supported by evidence?
Where do new compounds get added?
Every area leads to the same standard
Different questions, different literatures — one purity floor, one certificate per batch, one honest description at a time.
For laboratory and research use only. Not for human or animal consumption. Not a medicine and not a food supplement. Sold to persons aged 18 and over.
